Cargando…
Neurotoxic syndrome induced by clomipramine plus risperidone in a patient with autistic spectrum disorder: serotonin or neuroleptic malignant syndrome?
To the best of our knowledge, there are no case studies of serotonin syndrome (SS) in patients with autism spectrum disorder. We report the case of a 33-year-old male who presented SS under the combined use of clomipramine and risperidone. More specifically, within 2 days after clomipramine (10 mg/B...
Autores principales: | Nikolaou, Kalliopi N., Gournellis, Rossetos, Michopoulos, Ioannis, Dervenoulas, Georgios, Christodoulou, Christos, Douzenis, Athanasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650401/ https://www.ncbi.nlm.nih.gov/pubmed/26583039 http://dx.doi.org/10.1186/s12991-015-0073-z |
Ejemplares similares
-
A case of neurocysticercosis: Neuropsychiatric manifestations, course, and treatment
por: Gournellis, Rossetos, et al.
Publicado: (2019) -
Psychotic (delusional) depression and completed suicide: a systematic review and meta-analysis
por: Gournellis, Rossetos, et al.
Publicado: (2018) -
Smoking reduction in psychiatric inpatients is feasible: results from a 12-month prospective study
por: Michopoulos, Ioannis, et al.
Publicado: (2015) -
Serotonin Syndrome after Clomipramine Overdose in a Child
por: Direk, Meltem Çobanoğulları, et al.
Publicado: (2016) -
Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome?
por: Kontaxakis, Vassilis P, et al.
Publicado: (2003)